Yıl: 2022 Cilt: 19 Sayı: 2 Sayfa Aralığı: 104 - 110 Metin Dili: İngilizce DOI: 10.4274/tjod.galenos.2022.25307 İndeks Tarihi: 18-07-2022

Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study

Öz:
Objective: Preeclampsia is a highly morbid disease of placental origin, life-threatening condition for both a pregnant woman and her fetus. Cadherin 6 and 11 are adhesion molecules that play an important role in trophoblastic development and placentation. In our study, we investigated the change in serum cadherin 6 and 11 levels in pregnant women with preeclampsia. Materials and Methods: Pregnant women with preeclampsia were selected and compared with healthy women (as a control group) for a one-year study. The serum alanine aminotransferase, aspartate aminotransferase, and cadherin levels 6 and 11 of participants were analyzed and compared. Results: A total of 189 pregnant women were subdivided into 2 groups as preeclamptic (n=94) and women with healthy pregnancy (n=95). The cadherin 6 and cadherin 11 levels of the preeclamptic patients were significantly higher than those in the control group (p=0.001), and they were found to be significantly higher mainly in patients with early-onset and severe preeclampsia group (p=0.001). The cut-off cadherin 6 and 11 values for severe preeclampsia were found as 98.174 ng/mL and 1.92 ng/mL; with sensitivity of 88.3% and 84% respectively (p=0.001). Conclusion: The data analysis showed elevated serum cadherin 6 and 11 levels associated with the severity and early onset of pre-eclampsia. Serum cadherin 6 and 11 levels can be a candidate marker for the prediction of preeclampsia
Anahtar Kelime:

Erken başlangıçlı ve ağır preeklampsi ile serum kaderin 6 ve 11 seviyeleri arasındaki ilişki: Bir pilot çalışma

Öz:
Amaç: Preeklampsi, plasenta kaynaklı oldukça morbid bir hastalık olup, hem gebe hem de fetüs için hayatı tehdit edici bir durumdur. Kaderin 6 ve 11, plasenta oluşumu ve trofoblastik gelişimde önemli bir rol oynayan adezyon molekülleridir. Çalışmamızda, preeklampsi olan gebe kadınlarda serum kaderin 6 ve 11 seviyelerindeki değişimleri incelemeyi amaçladık. Gereç ve Yöntemler: Bir yıllık bir çalışma çerçevesinde preeklampsi olan gebeler seçildi ve kontrol grubu olarak sağlıklı gebelerle karşılaştırıldı. Katılımcıların serum alaninaminotransferaz, aspartate aminotransferaz, kaderin 6 ve 11 seviyeleri analiz edildi ve karşılaştırıldı. Bulgular: Toplam 189 gebe, preeklamptik (n=94) ve sağlıklı gebeliği olan (n=95) olmak üzere iki gruba bölünmüştür. Preeklamptik hastaların kaderin 6 ve kaderin 11 düzeyleri kontrol grubuna göre anlamlı olarak yüksekti (p=0,001) ve özellikle erken başlangıçlı ve şiddetli preeklampsili hastalarda anlamlı olarak yüksek bulundu (p=0,001). Şiddetli preeklampsi için cut-off kaderin 6 ve 11 değerleri sırasıyla %88,3 ve %84 duyarlılıkla, 174 ng/mL ve 1,92 ng/ mL olarak bulundu (p=0,001). Sonuç: Verilerin analizi, yüksek serum kaderin 6 ve 11 seviyelerinin preeklampsinin şiddeti ve erken başlangıcı ile ilişkili olduğunu gösterdi. Serum kaderin 6 ve 11 seviyeleri, preeklampsinin öngörülmesi için aday birer belirteç olabilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31.
  • 2. Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L; Global Pregnancy Collaboration. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension 2021;77:1430-41.
  • 3. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013;170:1-7.
  • 4. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012;36:56-9.
  • 5. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014;10:466-80.
  • 6. Brosens I, Pinjenborg R, Vercruysse L, Romero R. The “Great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 2012;204:193-201.
  • 7. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-64.
  • 8. Woods L, Perez-Garcia V, Hemberger M. Regulation of Placental Development and Its Impact on Fetal Growth-New Insights From Mouse Models. Front Endocrinol (Lausanne). 2018;9:570.
  • 9. Yang J, Weinberg RA. Review Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-29.
  • 10. Yang J, Antin P, Berx G, Blanpain C, Brabetz T, Bronner M, et al. Guidelines and definitions for research on epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 2020;21:341-52.
  • 11. Vincent-salomon A, Thiery JP. Host microenvironment in breast cancer development epithelial – mesenchymal transition in breast cancer development. Breast Cancer Res 2003;5:101-6.
  • 12. Nollet F, Kools P, Roy F Van. Phylogenetic Analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000;299:551-72.
  • 13. Zaidel-bar R. Cadherin adhesome at a glance. J Cell Sci 2013;126:373- 78.
  • 14. Inoue YU, Asami J, Inoue T. Cadherin-6 gene regulatory patterns in the postnatal mouse brain. Mol Cel Neurosci 2008;39:95-104.
  • 15. Jia L, Liu F, Hansen SH, Martin BA, Zegers MMP, Mostov KE. Distinct roles of cadherin-6 and E-cadherin in tubulogenesis and lumen formation. M Biol Cell 2011;22:2031-41.
  • 16. Paul R, Necknig U, Busch R, Ewing CM, Hartung R, Isaacs WB. Cadherin-6: A new prognostic marker for renal cell carcinoma. J Urol 2004;171:97-101.
  • 17. MacCalman CD, Getsios S, Chen GTC. Type 2 Cadherins in the human endometrium and placenta: Their putative roles in human implantation and placentation. Am J Reprod Immunol 1998;39:96-107.
  • 18. Kii I, Amizuka N, Shimomura J, Saga Y, Kudo A. Cell–cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro- lineage. J Bone Miner Res 2004;19:1840-9.
  • 19. Marthiens V, Gavard J, Padilla F, Monnet C, Castellani V, Lambert M, et al. A novel function for cadherin-11 in the regulation of motor axon elongation and fasciculation. Mol Cell Neurosci 2005;28:715-26.
  • 20. Getsios S, MacCalman CD. Cadherin-11 modulates the terminal differentiation and fusion of human trophoblastic cells in vitro. Dev Biol 2003;257:41-54.
  • 21. Karahoda R, Zaugg J, Fuenzalinde B, Kallol S, Moser-Haessig R, Staud F, et al. Trophoblast differentiation affects crucial nutritive functions of placental membrane transporters. Front Cell Dev Biol 2022;10:820286.
  • 22. Getsios S, Chen GT, Stephenson MD, Leclerc P, Blaschuk OW, MacCalman CD. Regulated expression of cadherin-6 and cadherin-11 in the glandular epithelial and stromal cells of the human endometrium. Dev Dyn 1998;211:238-47.
  • 23. Dunne E, Spring CM, Reheman A, Jin W, Berndt MC, Newman DK, et al. Cadherin 6 has a functional role in platelet aggregation and thrombus formation. Arter Thromb Vasc Biol 2014;32:1724-31.
  • 24. Bouck EG, Fuente M De, Zunica ER, Li W, Mumaw MM, Nieman MT, et al. Cadherin-6 mediates thrombosis in vivo. BioRxiv 2020;1-13.
  • 25. Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol 2019;15:275-89.
  • 26. Garrido-Gomez T, Dominguez F, Quiñonero A, Diaz-Gimeno P, Kapidzic M, Gormley M, et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc Natl Acad Sci U S A 2017;114:E8468-E8477.
  • 27. Getsios S, Chen GT, Huang DT, MacCalman CD. Regulated expression of cadherin-11 in human extravillous cytotrophoblasts undergoing aggregation and fusion in response to transforming growth factor beta 1. J Reprod Fertil 1998;114:357-63.
  • 28. Xue WC, Feng HC, Tsao SW, Chan KY, Ngan HY, Chiu PM, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer 2003;13:879- 88.
  • 29. Massalska D, Bijok J, Kucińska-Chahwan A, Zimowski JG, Ozdarska K, Panek G, et al. Triploid pregnancy-Clinical implications. Clin Genet 2021;100:368-75.
APA GÜVEY H, Soyer çalışkan C, çelik s, YURTCU N, hatirnaz s, AVCI B, Tinelli A (2022). Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. , 104 - 110. 10.4274/tjod.galenos.2022.25307
Chicago GÜVEY HURİ,Soyer çalışkan Canan,çelik samettin,YURTCU NAZAN,hatirnaz safak,AVCI BAHATTIN,Tinelli Andrea Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. (2022): 104 - 110. 10.4274/tjod.galenos.2022.25307
MLA GÜVEY HURİ,Soyer çalışkan Canan,çelik samettin,YURTCU NAZAN,hatirnaz safak,AVCI BAHATTIN,Tinelli Andrea Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. , 2022, ss.104 - 110. 10.4274/tjod.galenos.2022.25307
AMA GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. . 2022; 104 - 110. 10.4274/tjod.galenos.2022.25307
Vancouver GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. . 2022; 104 - 110. 10.4274/tjod.galenos.2022.25307
IEEE GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A "Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study." , ss.104 - 110, 2022. 10.4274/tjod.galenos.2022.25307
ISNAD GÜVEY, HURİ vd. "Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study". (2022), 104-110. https://doi.org/10.4274/tjod.galenos.2022.25307
APA GÜVEY H, Soyer çalışkan C, çelik s, YURTCU N, hatirnaz s, AVCI B, Tinelli A (2022). Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. Turkish Journal of Obstetrics and Gynecology, 19(2), 104 - 110. 10.4274/tjod.galenos.2022.25307
Chicago GÜVEY HURİ,Soyer çalışkan Canan,çelik samettin,YURTCU NAZAN,hatirnaz safak,AVCI BAHATTIN,Tinelli Andrea Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. Turkish Journal of Obstetrics and Gynecology 19, no.2 (2022): 104 - 110. 10.4274/tjod.galenos.2022.25307
MLA GÜVEY HURİ,Soyer çalışkan Canan,çelik samettin,YURTCU NAZAN,hatirnaz safak,AVCI BAHATTIN,Tinelli Andrea Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. Turkish Journal of Obstetrics and Gynecology, vol.19, no.2, 2022, ss.104 - 110. 10.4274/tjod.galenos.2022.25307
AMA GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. Turkish Journal of Obstetrics and Gynecology. 2022; 19(2): 104 - 110. 10.4274/tjod.galenos.2022.25307
Vancouver GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study. Turkish Journal of Obstetrics and Gynecology. 2022; 19(2): 104 - 110. 10.4274/tjod.galenos.2022.25307
IEEE GÜVEY H,Soyer çalışkan C,çelik s,YURTCU N,hatirnaz s,AVCI B,Tinelli A "Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study." Turkish Journal of Obstetrics and Gynecology, 19, ss.104 - 110, 2022. 10.4274/tjod.galenos.2022.25307
ISNAD GÜVEY, HURİ vd. "Relationship between serum cadherin 6 and 11 levels and severe and early-onset preeclampsia: A pilot study". Turkish Journal of Obstetrics and Gynecology 19/2 (2022), 104-110. https://doi.org/10.4274/tjod.galenos.2022.25307